Global Morphine Hydrochloride Market Growth 2026-2032
The global Morphine Hydrochloride market size is predicted to grow from US$ 1957 million in 2025 to US$ 2456 million in 2032; it is expected to grow at a CAGR of 3.3% from 2026 to 2032.
In 2025, global Morphine Hydrochloride output reached about 8 billion dosage units and global capacity of around 9 billion dosage units. The average price is about USD 0.25 per dosage unit, with gross margins near 45%. Morphine Hydrochloride is a pharmaceutical-grade opioid analgesic produced by converting purified morphine base, which is extracted primarily from opium poppy (Papaver somniferum) straw or opium latex, into its hydrochloride salt to improve stability, solubility, and formulation flexibility for oral, injectable, and other dosage forms used in the management of moderate to severe pain. The supply chain begins with the licensed cultivation of opium poppies under strict government regulation, followed by the extraction and purification of morphine alkaloids, chemical conversion to morphine hydrochloride through pharmaceutical synthesis and salt formation, crystallization, drying, and quality control compliant with GMP and pharmacopeial standards (USP, EP, BP, or JP). The active pharmaceutical ingredient (API) is then supplied to pharmaceutical manufacturers for formulation into tablets, capsules, oral solutions, injections, and controlled-release products, followed by packaging, regulatory release, and distribution through tightly controlled pharmaceutical wholesalers, hospitals, clinics, pharmacies, and authorized healthcare providers under national and international narcotics regulations.
The Morphine Hydrochloride market is growing steadily due to the increasing global incidence of cancer, postoperative pain, trauma, and chronic pain requiring strong opioid analgesics, as well as rising demand for effective pain management in palliative and end-of-life care. Market growth is further supported by the expansion of healthcare infrastructure in emerging economies, increasing numbers of surgical procedures, aging populations with higher pain prevalence, and broader access to essential pain medicines through government and international healthcare initiatives. Additional growth opportunities come from the development of abuse-deterrent and extended-release formulations, improved hospital pain management protocols, and the expansion of injectable morphine use in emergency and critical care settings. However, market expansion is moderated by stringent narcotics regulations, opioid stewardship programs, concerns over misuse and addiction, and increasing adoption of multimodal pain management strategies that aim to reduce opioid consumption while maintaining adequate analgesia.
LP Information, Inc. (LPI) ' newest research report, the “Morphine Hydrochloride Industry Forecast” looks at past sales and reviews total world Morphine Hydrochloride sales in 2025, providing a comprehensive analysis by region and market sector of projected Morphine Hydrochloride sales for 2026 through 2032. With Morphine Hydrochloride sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Morphine Hydrochloride industry.
This Insight Report provides a comprehensive analysis of the global Morphine Hydrochloride landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Morphine Hydrochloride portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Morphine Hydrochloride market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Morphine Hydrochloride and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Morphine Hydrochloride.
This report presents a comprehensive overview, market shares, and growth opportunities of Morphine Hydrochloride market by product type, application, key manufacturers and key regions and countries.
In 2025, global Morphine Hydrochloride output reached about 8 billion dosage units and global capacity of around 9 billion dosage units. The average price is about USD 0.25 per dosage unit, with gross margins near 45%. Morphine Hydrochloride is a pharmaceutical-grade opioid analgesic produced by converting purified morphine base, which is extracted primarily from opium poppy (Papaver somniferum) straw or opium latex, into its hydrochloride salt to improve stability, solubility, and formulation flexibility for oral, injectable, and other dosage forms used in the management of moderate to severe pain. The supply chain begins with the licensed cultivation of opium poppies under strict government regulation, followed by the extraction and purification of morphine alkaloids, chemical conversion to morphine hydrochloride through pharmaceutical synthesis and salt formation, crystallization, drying, and quality control compliant with GMP and pharmacopeial standards (USP, EP, BP, or JP). The active pharmaceutical ingredient (API) is then supplied to pharmaceutical manufacturers for formulation into tablets, capsules, oral solutions, injections, and controlled-release products, followed by packaging, regulatory release, and distribution through tightly controlled pharmaceutical wholesalers, hospitals, clinics, pharmacies, and authorized healthcare providers under national and international narcotics regulations.
The Morphine Hydrochloride market is growing steadily due to the increasing global incidence of cancer, postoperative pain, trauma, and chronic pain requiring strong opioid analgesics, as well as rising demand for effective pain management in palliative and end-of-life care. Market growth is further supported by the expansion of healthcare infrastructure in emerging economies, increasing numbers of surgical procedures, aging populations with higher pain prevalence, and broader access to essential pain medicines through government and international healthcare initiatives. Additional growth opportunities come from the development of abuse-deterrent and extended-release formulations, improved hospital pain management protocols, and the expansion of injectable morphine use in emergency and critical care settings. However, market expansion is moderated by stringent narcotics regulations, opioid stewardship programs, concerns over misuse and addiction, and increasing adoption of multimodal pain management strategies that aim to reduce opioid consumption while maintaining adequate analgesia.
LP Information, Inc. (LPI) ' newest research report, the “Morphine Hydrochloride Industry Forecast” looks at past sales and reviews total world Morphine Hydrochloride sales in 2025, providing a comprehensive analysis by region and market sector of projected Morphine Hydrochloride sales for 2026 through 2032. With Morphine Hydrochloride sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Morphine Hydrochloride industry.
This Insight Report provides a comprehensive analysis of the global Morphine Hydrochloride landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Morphine Hydrochloride portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Morphine Hydrochloride market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Morphine Hydrochloride and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Morphine Hydrochloride.
This report presents a comprehensive overview, market shares, and growth opportunities of Morphine Hydrochloride market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Immediate-Release (IR)
- Controlled-Release (CR)
- Sustained-Release (SR)
Segmentation by Strength:
- <15 mg
- 15–30 mg
- 30–60 mg
- 60–100 mg
- >100 mg
Segmentation by Sterility:
- Sterile Injectable Grade
- Non-Sterile Oral Grade
Segmentation by Application:
- Acute Pain Management
- Chronic Pain Management
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Jiangsu Nhwa Pharmaceutical
- Humanwell Healthcare Group
- Mallinckrodt Pharmaceuticals
- Hikma Pharmaceuticals
- Viatris
- Pfizer
- Fresenius Kabi
- Hameln Pharma
- Teva Pharmaceutical
- Sun Pharmaceutical
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Morphine Hydrochloride market?
- What factors are driving Morphine Hydrochloride market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Morphine Hydrochloride market opportunities vary by end market size?
- How does Morphine Hydrochloride break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Morphine Hydrochloride Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Morphine Hydrochloride by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Morphine Hydrochloride by Country/Region, 2021, 2025 & 2032
2.2 Morphine Hydrochloride Segment by Type
2.2.1 Immediate-Release (IR)
2.2.2 Controlled-Release (CR)
2.2.3 Sustained-Release (SR)
2.2.4 Morphine Hydrochloride Sales by Type
2.2.4.1 Global Morphine Hydrochloride Sales Market Share by Type (2021-2026)
2.2.4.2 Global Morphine Hydrochloride Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Morphine Hydrochloride Sale Price by Type (2021-2026)
2.3 Morphine Hydrochloride Segment by Strength
2.3.1 <15 mg
2.3.2 15–30 mg
2.3.3 30–60 mg
2.3.4 60–100 mg
2.3.5 >100 mg
2.3.6 Morphine Hydrochloride Sales by Strength
2.3.6.1 Global Morphine Hydrochloride Sales Market Share by Strength (2021-2026)
2.3.6.2 Global Morphine Hydrochloride Revenue and Market Share by Strength (2021-2026)
2.3.6.3 Global Morphine Hydrochloride Sale Price by Strength (2021-2026)
2.4 Morphine Hydrochloride Segment by Sterility
2.4.1 Sterile Injectable Grade
2.4.2 Non-Sterile Oral Grade
2.4.3 Morphine Hydrochloride Sales by Sterility
2.4.3.1 Global Morphine Hydrochloride Sales Market Share by Sterility (2021-2026)
2.4.3.2 Global Morphine Hydrochloride Revenue and Market Share by Sterility (2021-2026)
2.4.3.3 Global Morphine Hydrochloride Sale Price by Sterility (2021-2026)
2.5 Morphine Hydrochloride Segment by Application
2.5.1 Acute Pain Management
2.5.2 Chronic Pain Management
2.5.3 Morphine Hydrochloride Sales by Application
2.5.3.1 Global Morphine Hydrochloride Sale Market Share by Application (2021-2026)
2.5.3.2 Global Morphine Hydrochloride Revenue and Market Share by Application (2021-2026)
2.5.3.3 Global Morphine Hydrochloride Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Morphine Hydrochloride Breakdown Data by Company
3.1.1 Global Morphine Hydrochloride Annual Sales by Company (2021-2026)
3.1.2 Global Morphine Hydrochloride Sales Market Share by Company (2021-2026)
3.2 Global Morphine Hydrochloride Annual Revenue by Company (2021-2026)
3.2.1 Global Morphine Hydrochloride Revenue by Company (2021-2026)
3.2.2 Global Morphine Hydrochloride Revenue Market Share by Company (2021-2026)
3.3 Global Morphine Hydrochloride Sale Price by Company
3.4 Key Manufacturers Morphine Hydrochloride Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Morphine Hydrochloride Product Location Distribution
3.4.2 Players Morphine Hydrochloride Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MORPHINE HYDROCHLORIDE BY GEOGRAPHIC REGION
4.1 World Historic Morphine Hydrochloride Market Size by Geographic Region (2021-2026)
4.1.1 Global Morphine Hydrochloride Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Morphine Hydrochloride Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Morphine Hydrochloride Market Size by Country/Region (2021-2026)
4.2.1 Global Morphine Hydrochloride Annual Sales by Country/Region (2021-2026)
4.2.2 Global Morphine Hydrochloride Annual Revenue by Country/Region (2021-2026)
4.3 Americas Morphine Hydrochloride Sales Growth
4.4 APAC Morphine Hydrochloride Sales Growth
4.5 Europe Morphine Hydrochloride Sales Growth
4.6 Middle East & Africa Morphine Hydrochloride Sales Growth
5 AMERICAS
5.1 Americas Morphine Hydrochloride Sales by Country
5.1.1 Americas Morphine Hydrochloride Sales by Country (2021-2026)
5.1.2 Americas Morphine Hydrochloride Revenue by Country (2021-2026)
5.2 Americas Morphine Hydrochloride Sales by Type (2021-2026)
5.3 Americas Morphine Hydrochloride Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Morphine Hydrochloride Sales by Region
6.1.1 APAC Morphine Hydrochloride Sales by Region (2021-2026)
6.1.2 APAC Morphine Hydrochloride Revenue by Region (2021-2026)
6.2 APAC Morphine Hydrochloride Sales by Type (2021-2026)
6.3 APAC Morphine Hydrochloride Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Morphine Hydrochloride by Country
7.1.1 Europe Morphine Hydrochloride Sales by Country (2021-2026)
7.1.2 Europe Morphine Hydrochloride Revenue by Country (2021-2026)
7.2 Europe Morphine Hydrochloride Sales by Type (2021-2026)
7.3 Europe Morphine Hydrochloride Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Morphine Hydrochloride by Country
8.1.1 Middle East & Africa Morphine Hydrochloride Sales by Country (2021-2026)
8.1.2 Middle East & Africa Morphine Hydrochloride Revenue by Country (2021-2026)
8.2 Middle East & Africa Morphine Hydrochloride Sales by Type (2021-2026)
8.3 Middle East & Africa Morphine Hydrochloride Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Morphine Hydrochloride
10.3 Manufacturing Process Analysis of Morphine Hydrochloride
10.4 Industry Chain Structure of Morphine Hydrochloride
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Morphine Hydrochloride Distributors
11.3 Morphine Hydrochloride Customer
12 WORLD FORECAST REVIEW FOR MORPHINE HYDROCHLORIDE BY GEOGRAPHIC REGION
12.1 Global Morphine Hydrochloride Market Size Forecast by Region
12.1.1 Global Morphine Hydrochloride Forecast by Region (2027-2032)
12.1.2 Global Morphine Hydrochloride Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Morphine Hydrochloride Forecast by Type (2027-2032)
12.7 Global Morphine Hydrochloride Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Jiangsu Nhwa Pharmaceutical
13.1.1 Jiangsu Nhwa Pharmaceutical Company Information
13.1.2 Jiangsu Nhwa Pharmaceutical Morphine Hydrochloride Product Portfolios and Specifications
13.1.3 Jiangsu Nhwa Pharmaceutical Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Jiangsu Nhwa Pharmaceutical Main Business Overview
13.1.5 Jiangsu Nhwa Pharmaceutical Latest Developments
13.2 Humanwell Healthcare Group
13.2.1 Humanwell Healthcare Group Company Information
13.2.2 Humanwell Healthcare Group Morphine Hydrochloride Product Portfolios and Specifications
13.2.3 Humanwell Healthcare Group Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Humanwell Healthcare Group Main Business Overview
13.2.5 Humanwell Healthcare Group Latest Developments
13.3 Mallinckrodt Pharmaceuticals
13.3.1 Mallinckrodt Pharmaceuticals Company Information
13.3.2 Mallinckrodt Pharmaceuticals Morphine Hydrochloride Product Portfolios and Specifications
13.3.3 Mallinckrodt Pharmaceuticals Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.3.5 Mallinckrodt Pharmaceuticals Latest Developments
13.4 Hikma Pharmaceuticals
13.4.1 Hikma Pharmaceuticals Company Information
13.4.2 Hikma Pharmaceuticals Morphine Hydrochloride Product Portfolios and Specifications
13.4.3 Hikma Pharmaceuticals Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Hikma Pharmaceuticals Main Business Overview
13.4.5 Hikma Pharmaceuticals Latest Developments
13.5 Viatris
13.5.1 Viatris Company Information
13.5.2 Viatris Morphine Hydrochloride Product Portfolios and Specifications
13.5.3 Viatris Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Viatris Main Business Overview
13.5.5 Viatris Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Morphine Hydrochloride Product Portfolios and Specifications
13.6.3 Pfizer Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Fresenius Kabi
13.7.1 Fresenius Kabi Company Information
13.7.2 Fresenius Kabi Morphine Hydrochloride Product Portfolios and Specifications
13.7.3 Fresenius Kabi Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Fresenius Kabi Main Business Overview
13.7.5 Fresenius Kabi Latest Developments
13.8 Hameln Pharma
13.8.1 Hameln Pharma Company Information
13.8.2 Hameln Pharma Morphine Hydrochloride Product Portfolios and Specifications
13.8.3 Hameln Pharma Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hameln Pharma Main Business Overview
13.8.5 Hameln Pharma Latest Developments
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Information
13.9.2 Teva Pharmaceutical Morphine Hydrochloride Product Portfolios and Specifications
13.9.3 Teva Pharmaceutical Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Teva Pharmaceutical Main Business Overview
13.9.5 Teva Pharmaceutical Latest Developments
13.10 Sun Pharmaceutical
13.10.1 Sun Pharmaceutical Company Information
13.10.2 Sun Pharmaceutical Morphine Hydrochloride Product Portfolios and Specifications
13.10.3 Sun Pharmaceutical Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sun Pharmaceutical Main Business Overview
13.10.5 Sun Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Morphine Hydrochloride Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Morphine Hydrochloride by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Morphine Hydrochloride by Country/Region, 2021, 2025 & 2032
2.2 Morphine Hydrochloride Segment by Type
2.2.1 Immediate-Release (IR)
2.2.2 Controlled-Release (CR)
2.2.3 Sustained-Release (SR)
2.2.4 Morphine Hydrochloride Sales by Type
2.2.4.1 Global Morphine Hydrochloride Sales Market Share by Type (2021-2026)
2.2.4.2 Global Morphine Hydrochloride Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Morphine Hydrochloride Sale Price by Type (2021-2026)
2.3 Morphine Hydrochloride Segment by Strength
2.3.1 <15 mg
2.3.2 15–30 mg
2.3.3 30–60 mg
2.3.4 60–100 mg
2.3.5 >100 mg
2.3.6 Morphine Hydrochloride Sales by Strength
2.3.6.1 Global Morphine Hydrochloride Sales Market Share by Strength (2021-2026)
2.3.6.2 Global Morphine Hydrochloride Revenue and Market Share by Strength (2021-2026)
2.3.6.3 Global Morphine Hydrochloride Sale Price by Strength (2021-2026)
2.4 Morphine Hydrochloride Segment by Sterility
2.4.1 Sterile Injectable Grade
2.4.2 Non-Sterile Oral Grade
2.4.3 Morphine Hydrochloride Sales by Sterility
2.4.3.1 Global Morphine Hydrochloride Sales Market Share by Sterility (2021-2026)
2.4.3.2 Global Morphine Hydrochloride Revenue and Market Share by Sterility (2021-2026)
2.4.3.3 Global Morphine Hydrochloride Sale Price by Sterility (2021-2026)
2.5 Morphine Hydrochloride Segment by Application
2.5.1 Acute Pain Management
2.5.2 Chronic Pain Management
2.5.3 Morphine Hydrochloride Sales by Application
2.5.3.1 Global Morphine Hydrochloride Sale Market Share by Application (2021-2026)
2.5.3.2 Global Morphine Hydrochloride Revenue and Market Share by Application (2021-2026)
2.5.3.3 Global Morphine Hydrochloride Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Morphine Hydrochloride Breakdown Data by Company
3.1.1 Global Morphine Hydrochloride Annual Sales by Company (2021-2026)
3.1.2 Global Morphine Hydrochloride Sales Market Share by Company (2021-2026)
3.2 Global Morphine Hydrochloride Annual Revenue by Company (2021-2026)
3.2.1 Global Morphine Hydrochloride Revenue by Company (2021-2026)
3.2.2 Global Morphine Hydrochloride Revenue Market Share by Company (2021-2026)
3.3 Global Morphine Hydrochloride Sale Price by Company
3.4 Key Manufacturers Morphine Hydrochloride Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Morphine Hydrochloride Product Location Distribution
3.4.2 Players Morphine Hydrochloride Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MORPHINE HYDROCHLORIDE BY GEOGRAPHIC REGION
4.1 World Historic Morphine Hydrochloride Market Size by Geographic Region (2021-2026)
4.1.1 Global Morphine Hydrochloride Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Morphine Hydrochloride Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Morphine Hydrochloride Market Size by Country/Region (2021-2026)
4.2.1 Global Morphine Hydrochloride Annual Sales by Country/Region (2021-2026)
4.2.2 Global Morphine Hydrochloride Annual Revenue by Country/Region (2021-2026)
4.3 Americas Morphine Hydrochloride Sales Growth
4.4 APAC Morphine Hydrochloride Sales Growth
4.5 Europe Morphine Hydrochloride Sales Growth
4.6 Middle East & Africa Morphine Hydrochloride Sales Growth
5 AMERICAS
5.1 Americas Morphine Hydrochloride Sales by Country
5.1.1 Americas Morphine Hydrochloride Sales by Country (2021-2026)
5.1.2 Americas Morphine Hydrochloride Revenue by Country (2021-2026)
5.2 Americas Morphine Hydrochloride Sales by Type (2021-2026)
5.3 Americas Morphine Hydrochloride Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Morphine Hydrochloride Sales by Region
6.1.1 APAC Morphine Hydrochloride Sales by Region (2021-2026)
6.1.2 APAC Morphine Hydrochloride Revenue by Region (2021-2026)
6.2 APAC Morphine Hydrochloride Sales by Type (2021-2026)
6.3 APAC Morphine Hydrochloride Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Morphine Hydrochloride by Country
7.1.1 Europe Morphine Hydrochloride Sales by Country (2021-2026)
7.1.2 Europe Morphine Hydrochloride Revenue by Country (2021-2026)
7.2 Europe Morphine Hydrochloride Sales by Type (2021-2026)
7.3 Europe Morphine Hydrochloride Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Morphine Hydrochloride by Country
8.1.1 Middle East & Africa Morphine Hydrochloride Sales by Country (2021-2026)
8.1.2 Middle East & Africa Morphine Hydrochloride Revenue by Country (2021-2026)
8.2 Middle East & Africa Morphine Hydrochloride Sales by Type (2021-2026)
8.3 Middle East & Africa Morphine Hydrochloride Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Morphine Hydrochloride
10.3 Manufacturing Process Analysis of Morphine Hydrochloride
10.4 Industry Chain Structure of Morphine Hydrochloride
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Morphine Hydrochloride Distributors
11.3 Morphine Hydrochloride Customer
12 WORLD FORECAST REVIEW FOR MORPHINE HYDROCHLORIDE BY GEOGRAPHIC REGION
12.1 Global Morphine Hydrochloride Market Size Forecast by Region
12.1.1 Global Morphine Hydrochloride Forecast by Region (2027-2032)
12.1.2 Global Morphine Hydrochloride Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Morphine Hydrochloride Forecast by Type (2027-2032)
12.7 Global Morphine Hydrochloride Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Jiangsu Nhwa Pharmaceutical
13.1.1 Jiangsu Nhwa Pharmaceutical Company Information
13.1.2 Jiangsu Nhwa Pharmaceutical Morphine Hydrochloride Product Portfolios and Specifications
13.1.3 Jiangsu Nhwa Pharmaceutical Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Jiangsu Nhwa Pharmaceutical Main Business Overview
13.1.5 Jiangsu Nhwa Pharmaceutical Latest Developments
13.2 Humanwell Healthcare Group
13.2.1 Humanwell Healthcare Group Company Information
13.2.2 Humanwell Healthcare Group Morphine Hydrochloride Product Portfolios and Specifications
13.2.3 Humanwell Healthcare Group Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Humanwell Healthcare Group Main Business Overview
13.2.5 Humanwell Healthcare Group Latest Developments
13.3 Mallinckrodt Pharmaceuticals
13.3.1 Mallinckrodt Pharmaceuticals Company Information
13.3.2 Mallinckrodt Pharmaceuticals Morphine Hydrochloride Product Portfolios and Specifications
13.3.3 Mallinckrodt Pharmaceuticals Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.3.5 Mallinckrodt Pharmaceuticals Latest Developments
13.4 Hikma Pharmaceuticals
13.4.1 Hikma Pharmaceuticals Company Information
13.4.2 Hikma Pharmaceuticals Morphine Hydrochloride Product Portfolios and Specifications
13.4.3 Hikma Pharmaceuticals Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Hikma Pharmaceuticals Main Business Overview
13.4.5 Hikma Pharmaceuticals Latest Developments
13.5 Viatris
13.5.1 Viatris Company Information
13.5.2 Viatris Morphine Hydrochloride Product Portfolios and Specifications
13.5.3 Viatris Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Viatris Main Business Overview
13.5.5 Viatris Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Morphine Hydrochloride Product Portfolios and Specifications
13.6.3 Pfizer Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Fresenius Kabi
13.7.1 Fresenius Kabi Company Information
13.7.2 Fresenius Kabi Morphine Hydrochloride Product Portfolios and Specifications
13.7.3 Fresenius Kabi Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Fresenius Kabi Main Business Overview
13.7.5 Fresenius Kabi Latest Developments
13.8 Hameln Pharma
13.8.1 Hameln Pharma Company Information
13.8.2 Hameln Pharma Morphine Hydrochloride Product Portfolios and Specifications
13.8.3 Hameln Pharma Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hameln Pharma Main Business Overview
13.8.5 Hameln Pharma Latest Developments
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Information
13.9.2 Teva Pharmaceutical Morphine Hydrochloride Product Portfolios and Specifications
13.9.3 Teva Pharmaceutical Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Teva Pharmaceutical Main Business Overview
13.9.5 Teva Pharmaceutical Latest Developments
13.10 Sun Pharmaceutical
13.10.1 Sun Pharmaceutical Company Information
13.10.2 Sun Pharmaceutical Morphine Hydrochloride Product Portfolios and Specifications
13.10.3 Sun Pharmaceutical Morphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sun Pharmaceutical Main Business Overview
13.10.5 Sun Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Morphine Hydrochloride Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Morphine Hydrochloride Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Immediate-Release (IR)
Table 4. Major Players of Controlled-Release (CR)
Table 5. Major Players of Sustained-Release (SR)
Table 6. Global Morphine Hydrochloride Sales by Type (2021-2026) & (K Units)
Table 7. Global Morphine Hydrochloride Sales Market Share by Type (2021-2026)
Table 8. Global Morphine Hydrochloride Revenue by Type (2021-2026) & ($ million)
Table 9. Global Morphine Hydrochloride Revenue Market Share by Type (2021-2026)
Table 10. Global Morphine Hydrochloride Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of <15 mg
Table 12. Major Players of 15–30 mg
Table 13. Major Players of 30–60 mg
Table 14. Major Players of 60–100 mg
Table 15. Major Players of >100 mg
Table 16. Global Morphine Hydrochloride Sales by Strength (2021-2026) & (K Units)
Table 17. Global Morphine Hydrochloride Sales Market Share by Strength (2021-2026)
Table 18. Global Morphine Hydrochloride Revenue by Strength (2021-2026) & ($ million)
Table 19. Global Morphine Hydrochloride Revenue Market Share by Strength (2021-2026)
Table 20. Global Morphine Hydrochloride Sale Price by Strength (2021-2026) & (US$/Unit)
Table 21. Major Players of Sterile Injectable Grade
Table 22. Major Players of Non-Sterile Oral Grade
Table 23. Global Morphine Hydrochloride Sales by Sterility (2021-2026) & (K Units)
Table 24. Global Morphine Hydrochloride Sales Market Share by Sterility (2021-2026)
Table 25. Global Morphine Hydrochloride Revenue by Sterility (2021-2026) & ($ million)
Table 26. Global Morphine Hydrochloride Revenue Market Share by Sterility (2021-2026)
Table 27. Global Morphine Hydrochloride Sale Price by Sterility (2021-2026) & (US$/Unit)
Table 28. Global Morphine Hydrochloride Sale by Application (2021-2026) & (K Units)
Table 29. Global Morphine Hydrochloride Sale Market Share by Application (2021-2026)
Table 30. Global Morphine Hydrochloride Revenue by Application (2021-2026) & ($ million)
Table 31. Global Morphine Hydrochloride Revenue Market Share by Application (2021-2026)
Table 32. Global Morphine Hydrochloride Sale Price by Application (2021-2026) & (US$/Unit)
Table 33. Global Morphine Hydrochloride Sales by Company (2021-2026) & (K Units)
Table 34. Global Morphine Hydrochloride Sales Market Share by Company (2021-2026)
Table 35. Global Morphine Hydrochloride Revenue by Company (2021-2026) & ($ millions)
Table 36. Global Morphine Hydrochloride Revenue Market Share by Company (2021-2026)
Table 37. Global Morphine Hydrochloride Sale Price by Company (2021-2026) & (US$/Unit)
Table 38. Key Manufacturers Morphine Hydrochloride Producing Area Distribution and Sales Area
Table 39. Players Morphine Hydrochloride Products Offered
Table 40. Morphine Hydrochloride Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 41. New Products and Potential Entrants
Table 42. Market M&A Activity & Strategy
Table 43. Global Morphine Hydrochloride Sales by Geographic Region (2021-2026) & (K Units)
Table 44. Global Morphine Hydrochloride Sales Market Share Geographic Region (2021-2026)
Table 45. Global Morphine Hydrochloride Revenue by Geographic Region (2021-2026) & ($ millions)
Table 46. Global Morphine Hydrochloride Revenue Market Share by Geographic Region (2021-2026)
Table 47. Global Morphine Hydrochloride Sales by Country/Region (2021-2026) & (K Units)
Table 48. Global Morphine Hydrochloride Sales Market Share by Country/Region (2021-2026)
Table 49. Global Morphine Hydrochloride Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global Morphine Hydrochloride Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas Morphine Hydrochloride Sales by Country (2021-2026) & (K Units)
Table 52. Americas Morphine Hydrochloride Sales Market Share by Country (2021-2026)
Table 53. Americas Morphine Hydrochloride Revenue by Country (2021-2026) & ($ millions)
Table 54. Americas Morphine Hydrochloride Sales by Type (2021-2026) & (K Units)
Table 55. Americas Morphine Hydrochloride Sales by Application (2021-2026) & (K Units)
Table 56. APAC Morphine Hydrochloride Sales by Region (2021-2026) & (K Units)
Table 57. APAC Morphine Hydrochloride Sales Market Share by Region (2021-2026)
Table 58. APAC Morphine Hydrochloride Revenue by Region (2021-2026) & ($ millions)
Table 59. APAC Morphine Hydrochloride Sales by Type (2021-2026) & (K Units)
Table 60. APAC Morphine Hydrochloride Sales by Application (2021-2026) & (K Units)
Table 61. Europe Morphine Hydrochloride Sales by Country (2021-2026) & (K Units)
Table 62. Europe Morphine Hydrochloride Revenue by Country (2021-2026) & ($ millions)
Table 63. Europe Morphine Hydrochloride Sales by Type (2021-2026) & (K Units)
Table 64. Europe Morphine Hydrochloride Sales by Application (2021-2026) & (K Units)
Table 65. Middle East & Africa Morphine Hydrochloride Sales by Country (2021-2026) & (K Units)
Table 66. Middle East & Africa Morphine Hydrochloride Revenue Market Share by Country (2021-2026)
Table 67. Middle East & Africa Morphine Hydrochloride Sales by Type (2021-2026) & (K Units)
Table 68. Middle East & Africa Morphine Hydrochloride Sales by Application (2021-2026) & (K Units)
Table 69. Key Market Drivers & Growth Opportunities of Morphine Hydrochloride
Table 70. Key Market Challenges & Risks of Morphine Hydrochloride
Table 71. Key Industry Trends of Morphine Hydrochloride
Table 72. Morphine Hydrochloride Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Morphine Hydrochloride Distributors List
Table 75. Morphine Hydrochloride Customer List
Table 76. Global Morphine Hydrochloride Sales Forecast by Region (2027-2032) & (K Units)
Table 77. Global Morphine Hydrochloride Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Americas Morphine Hydrochloride Sales Forecast by Country (2027-2032) & (K Units)
Table 79. Americas Morphine Hydrochloride Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. APAC Morphine Hydrochloride Sales Forecast by Region (2027-2032) & (K Units)
Table 81. APAC Morphine Hydrochloride Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Europe Morphine Hydrochloride Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Europe Morphine Hydrochloride Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Middle East & Africa Morphine Hydrochloride Sales Forecast by Country (2027-2032) & (K Units)
Table 85. Middle East & Africa Morphine Hydrochloride Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Global Morphine Hydrochloride Sales Forecast by Type (2027-2032) & (K Units)
Table 87. Global Morphine Hydrochloride Revenue Forecast by Type (2027-2032) & ($ millions)
Table 88. Global Morphine Hydrochloride Sales Forecast by Application (2027-2032) & (K Units)
Table 89. Global Morphine Hydrochloride Revenue Forecast by Application (2027-2032) & ($ millions)
Table 90. Jiangsu Nhwa Pharmaceutical Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 91. Jiangsu Nhwa Pharmaceutical Morphine Hydrochloride Product Portfolios and Specifications
Table 92. Jiangsu Nhwa Pharmaceutical Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Jiangsu Nhwa Pharmaceutical Main Business
Table 94. Jiangsu Nhwa Pharmaceutical Latest Developments
Table 95. Humanwell Healthcare Group Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 96. Humanwell Healthcare Group Morphine Hydrochloride Product Portfolios and Specifications
Table 97. Humanwell Healthcare Group Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Humanwell Healthcare Group Main Business
Table 99. Humanwell Healthcare Group Latest Developments
Table 100. Mallinckrodt Pharmaceuticals Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 101. Mallinckrodt Pharmaceuticals Morphine Hydrochloride Product Portfolios and Specifications
Table 102. Mallinckrodt Pharmaceuticals Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Mallinckrodt Pharmaceuticals Main Business
Table 104. Mallinckrodt Pharmaceuticals Latest Developments
Table 105. Hikma Pharmaceuticals Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 106. Hikma Pharmaceuticals Morphine Hydrochloride Product Portfolios and Specifications
Table 107. Hikma Pharmaceuticals Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Hikma Pharmaceuticals Main Business
Table 109. Hikma Pharmaceuticals Latest Developments
Table 110. Viatris Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 111. Viatris Morphine Hydrochloride Product Portfolios and Specifications
Table 112. Viatris Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Viatris Main Business
Table 114. Viatris Latest Developments
Table 115. Pfizer Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 116. Pfizer Morphine Hydrochloride Product Portfolios and Specifications
Table 117. Pfizer Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Pfizer Main Business
Table 119. Pfizer Latest Developments
Table 120. Fresenius Kabi Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 121. Fresenius Kabi Morphine Hydrochloride Product Portfolios and Specifications
Table 122. Fresenius Kabi Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Fresenius Kabi Main Business
Table 124. Fresenius Kabi Latest Developments
Table 125. Hameln Pharma Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 126. Hameln Pharma Morphine Hydrochloride Product Portfolios and Specifications
Table 127. Hameln Pharma Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Hameln Pharma Main Business
Table 129. Hameln Pharma Latest Developments
Table 130. Teva Pharmaceutical Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 131. Teva Pharmaceutical Morphine Hydrochloride Product Portfolios and Specifications
Table 132. Teva Pharmaceutical Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Teva Pharmaceutical Main Business
Table 134. Teva Pharmaceutical Latest Developments
Table 135. Sun Pharmaceutical Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 136. Sun Pharmaceutical Morphine Hydrochloride Product Portfolios and Specifications
Table 137. Sun Pharmaceutical Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Sun Pharmaceutical Main Business
Table 139. Sun Pharmaceutical Latest Developments
Table 1. Morphine Hydrochloride Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Morphine Hydrochloride Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Immediate-Release (IR)
Table 4. Major Players of Controlled-Release (CR)
Table 5. Major Players of Sustained-Release (SR)
Table 6. Global Morphine Hydrochloride Sales by Type (2021-2026) & (K Units)
Table 7. Global Morphine Hydrochloride Sales Market Share by Type (2021-2026)
Table 8. Global Morphine Hydrochloride Revenue by Type (2021-2026) & ($ million)
Table 9. Global Morphine Hydrochloride Revenue Market Share by Type (2021-2026)
Table 10. Global Morphine Hydrochloride Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of <15 mg
Table 12. Major Players of 15–30 mg
Table 13. Major Players of 30–60 mg
Table 14. Major Players of 60–100 mg
Table 15. Major Players of >100 mg
Table 16. Global Morphine Hydrochloride Sales by Strength (2021-2026) & (K Units)
Table 17. Global Morphine Hydrochloride Sales Market Share by Strength (2021-2026)
Table 18. Global Morphine Hydrochloride Revenue by Strength (2021-2026) & ($ million)
Table 19. Global Morphine Hydrochloride Revenue Market Share by Strength (2021-2026)
Table 20. Global Morphine Hydrochloride Sale Price by Strength (2021-2026) & (US$/Unit)
Table 21. Major Players of Sterile Injectable Grade
Table 22. Major Players of Non-Sterile Oral Grade
Table 23. Global Morphine Hydrochloride Sales by Sterility (2021-2026) & (K Units)
Table 24. Global Morphine Hydrochloride Sales Market Share by Sterility (2021-2026)
Table 25. Global Morphine Hydrochloride Revenue by Sterility (2021-2026) & ($ million)
Table 26. Global Morphine Hydrochloride Revenue Market Share by Sterility (2021-2026)
Table 27. Global Morphine Hydrochloride Sale Price by Sterility (2021-2026) & (US$/Unit)
Table 28. Global Morphine Hydrochloride Sale by Application (2021-2026) & (K Units)
Table 29. Global Morphine Hydrochloride Sale Market Share by Application (2021-2026)
Table 30. Global Morphine Hydrochloride Revenue by Application (2021-2026) & ($ million)
Table 31. Global Morphine Hydrochloride Revenue Market Share by Application (2021-2026)
Table 32. Global Morphine Hydrochloride Sale Price by Application (2021-2026) & (US$/Unit)
Table 33. Global Morphine Hydrochloride Sales by Company (2021-2026) & (K Units)
Table 34. Global Morphine Hydrochloride Sales Market Share by Company (2021-2026)
Table 35. Global Morphine Hydrochloride Revenue by Company (2021-2026) & ($ millions)
Table 36. Global Morphine Hydrochloride Revenue Market Share by Company (2021-2026)
Table 37. Global Morphine Hydrochloride Sale Price by Company (2021-2026) & (US$/Unit)
Table 38. Key Manufacturers Morphine Hydrochloride Producing Area Distribution and Sales Area
Table 39. Players Morphine Hydrochloride Products Offered
Table 40. Morphine Hydrochloride Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 41. New Products and Potential Entrants
Table 42. Market M&A Activity & Strategy
Table 43. Global Morphine Hydrochloride Sales by Geographic Region (2021-2026) & (K Units)
Table 44. Global Morphine Hydrochloride Sales Market Share Geographic Region (2021-2026)
Table 45. Global Morphine Hydrochloride Revenue by Geographic Region (2021-2026) & ($ millions)
Table 46. Global Morphine Hydrochloride Revenue Market Share by Geographic Region (2021-2026)
Table 47. Global Morphine Hydrochloride Sales by Country/Region (2021-2026) & (K Units)
Table 48. Global Morphine Hydrochloride Sales Market Share by Country/Region (2021-2026)
Table 49. Global Morphine Hydrochloride Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global Morphine Hydrochloride Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas Morphine Hydrochloride Sales by Country (2021-2026) & (K Units)
Table 52. Americas Morphine Hydrochloride Sales Market Share by Country (2021-2026)
Table 53. Americas Morphine Hydrochloride Revenue by Country (2021-2026) & ($ millions)
Table 54. Americas Morphine Hydrochloride Sales by Type (2021-2026) & (K Units)
Table 55. Americas Morphine Hydrochloride Sales by Application (2021-2026) & (K Units)
Table 56. APAC Morphine Hydrochloride Sales by Region (2021-2026) & (K Units)
Table 57. APAC Morphine Hydrochloride Sales Market Share by Region (2021-2026)
Table 58. APAC Morphine Hydrochloride Revenue by Region (2021-2026) & ($ millions)
Table 59. APAC Morphine Hydrochloride Sales by Type (2021-2026) & (K Units)
Table 60. APAC Morphine Hydrochloride Sales by Application (2021-2026) & (K Units)
Table 61. Europe Morphine Hydrochloride Sales by Country (2021-2026) & (K Units)
Table 62. Europe Morphine Hydrochloride Revenue by Country (2021-2026) & ($ millions)
Table 63. Europe Morphine Hydrochloride Sales by Type (2021-2026) & (K Units)
Table 64. Europe Morphine Hydrochloride Sales by Application (2021-2026) & (K Units)
Table 65. Middle East & Africa Morphine Hydrochloride Sales by Country (2021-2026) & (K Units)
Table 66. Middle East & Africa Morphine Hydrochloride Revenue Market Share by Country (2021-2026)
Table 67. Middle East & Africa Morphine Hydrochloride Sales by Type (2021-2026) & (K Units)
Table 68. Middle East & Africa Morphine Hydrochloride Sales by Application (2021-2026) & (K Units)
Table 69. Key Market Drivers & Growth Opportunities of Morphine Hydrochloride
Table 70. Key Market Challenges & Risks of Morphine Hydrochloride
Table 71. Key Industry Trends of Morphine Hydrochloride
Table 72. Morphine Hydrochloride Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Morphine Hydrochloride Distributors List
Table 75. Morphine Hydrochloride Customer List
Table 76. Global Morphine Hydrochloride Sales Forecast by Region (2027-2032) & (K Units)
Table 77. Global Morphine Hydrochloride Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Americas Morphine Hydrochloride Sales Forecast by Country (2027-2032) & (K Units)
Table 79. Americas Morphine Hydrochloride Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. APAC Morphine Hydrochloride Sales Forecast by Region (2027-2032) & (K Units)
Table 81. APAC Morphine Hydrochloride Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Europe Morphine Hydrochloride Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Europe Morphine Hydrochloride Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Middle East & Africa Morphine Hydrochloride Sales Forecast by Country (2027-2032) & (K Units)
Table 85. Middle East & Africa Morphine Hydrochloride Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Global Morphine Hydrochloride Sales Forecast by Type (2027-2032) & (K Units)
Table 87. Global Morphine Hydrochloride Revenue Forecast by Type (2027-2032) & ($ millions)
Table 88. Global Morphine Hydrochloride Sales Forecast by Application (2027-2032) & (K Units)
Table 89. Global Morphine Hydrochloride Revenue Forecast by Application (2027-2032) & ($ millions)
Table 90. Jiangsu Nhwa Pharmaceutical Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 91. Jiangsu Nhwa Pharmaceutical Morphine Hydrochloride Product Portfolios and Specifications
Table 92. Jiangsu Nhwa Pharmaceutical Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Jiangsu Nhwa Pharmaceutical Main Business
Table 94. Jiangsu Nhwa Pharmaceutical Latest Developments
Table 95. Humanwell Healthcare Group Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 96. Humanwell Healthcare Group Morphine Hydrochloride Product Portfolios and Specifications
Table 97. Humanwell Healthcare Group Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Humanwell Healthcare Group Main Business
Table 99. Humanwell Healthcare Group Latest Developments
Table 100. Mallinckrodt Pharmaceuticals Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 101. Mallinckrodt Pharmaceuticals Morphine Hydrochloride Product Portfolios and Specifications
Table 102. Mallinckrodt Pharmaceuticals Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Mallinckrodt Pharmaceuticals Main Business
Table 104. Mallinckrodt Pharmaceuticals Latest Developments
Table 105. Hikma Pharmaceuticals Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 106. Hikma Pharmaceuticals Morphine Hydrochloride Product Portfolios and Specifications
Table 107. Hikma Pharmaceuticals Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Hikma Pharmaceuticals Main Business
Table 109. Hikma Pharmaceuticals Latest Developments
Table 110. Viatris Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 111. Viatris Morphine Hydrochloride Product Portfolios and Specifications
Table 112. Viatris Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Viatris Main Business
Table 114. Viatris Latest Developments
Table 115. Pfizer Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 116. Pfizer Morphine Hydrochloride Product Portfolios and Specifications
Table 117. Pfizer Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Pfizer Main Business
Table 119. Pfizer Latest Developments
Table 120. Fresenius Kabi Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 121. Fresenius Kabi Morphine Hydrochloride Product Portfolios and Specifications
Table 122. Fresenius Kabi Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Fresenius Kabi Main Business
Table 124. Fresenius Kabi Latest Developments
Table 125. Hameln Pharma Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 126. Hameln Pharma Morphine Hydrochloride Product Portfolios and Specifications
Table 127. Hameln Pharma Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Hameln Pharma Main Business
Table 129. Hameln Pharma Latest Developments
Table 130. Teva Pharmaceutical Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 131. Teva Pharmaceutical Morphine Hydrochloride Product Portfolios and Specifications
Table 132. Teva Pharmaceutical Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Teva Pharmaceutical Main Business
Table 134. Teva Pharmaceutical Latest Developments
Table 135. Sun Pharmaceutical Basic Information, Morphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 136. Sun Pharmaceutical Morphine Hydrochloride Product Portfolios and Specifications
Table 137. Sun Pharmaceutical Morphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Sun Pharmaceutical Main Business
Table 139. Sun Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Morphine Hydrochloride
Figure 2. Morphine Hydrochloride Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Morphine Hydrochloride Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Morphine Hydrochloride Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Morphine Hydrochloride Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Morphine Hydrochloride Sales Market Share by Country/Region (2025)
Figure 10. Morphine Hydrochloride Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Immediate-Release (IR)
Figure 12. Product Picture of Controlled-Release (CR)
Figure 13. Product Picture of Sustained-Release (SR)
Figure 14. Global Morphine Hydrochloride Sales Market Share by Type in 2026
Figure 15. Global Morphine Hydrochloride Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of <15 mg
Figure 17. Product Picture of 15–30 mg
Figure 18. Product Picture of 30–60 mg
Figure 19. Product Picture of 60–100 mg
Figure 20. Product Picture of >100 mg
Figure 21. Global Morphine Hydrochloride Sales Market Share by Strength in 2026
Figure 22. Global Morphine Hydrochloride Revenue Market Share by Strength (2021-2026)
Figure 23. Product Picture of Sterile Injectable Grade
Figure 24. Product Picture of Non-Sterile Oral Grade
Figure 25. Global Morphine Hydrochloride Sales Market Share by Sterility in 2026
Figure 26. Global Morphine Hydrochloride Revenue Market Share by Sterility (2021-2026)
Figure 27. Morphine Hydrochloride Consumed in Acute Pain Management
Figure 28. Global Morphine Hydrochloride Market: Acute Pain Management (2021-2026) & (K Units)
Figure 29. Morphine Hydrochloride Consumed in Chronic Pain Management
Figure 30. Global Morphine Hydrochloride Market: Chronic Pain Management (2021-2026) & (K Units)
Figure 31. Global Morphine Hydrochloride Sale Market Share by Application (2025)
Figure 32. Global Morphine Hydrochloride Revenue Market Share by Application in 2025
Figure 33. Morphine Hydrochloride Sales by Company in 2025 (K Units)
Figure 34. Global Morphine Hydrochloride Sales Market Share by Company in 2025
Figure 35. Morphine Hydrochloride Revenue by Company in 2025 ($ millions)
Figure 36. Global Morphine Hydrochloride Revenue Market Share by Company in 2025
Figure 37. Global Morphine Hydrochloride Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Morphine Hydrochloride Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Morphine Hydrochloride Sales 2021-2026 (K Units)
Figure 40. Americas Morphine Hydrochloride Revenue 2021-2026 ($ millions)
Figure 41. APAC Morphine Hydrochloride Sales 2021-2026 (K Units)
Figure 42. APAC Morphine Hydrochloride Revenue 2021-2026 ($ millions)
Figure 43. Europe Morphine Hydrochloride Sales 2021-2026 (K Units)
Figure 44. Europe Morphine Hydrochloride Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Morphine Hydrochloride Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Morphine Hydrochloride Revenue 2021-2026 ($ millions)
Figure 47. Americas Morphine Hydrochloride Sales Market Share by Country in 2025
Figure 48. Americas Morphine Hydrochloride Revenue Market Share by Country (2021-2026)
Figure 49. Americas Morphine Hydrochloride Sales Market Share by Type (2021-2026)
Figure 50. Americas Morphine Hydrochloride Sales Market Share by Application (2021-2026)
Figure 51. United States Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Morphine Hydrochloride Sales Market Share by Region in 2025
Figure 56. APAC Morphine Hydrochloride Revenue Market Share by Region (2021-2026)
Figure 57. APAC Morphine Hydrochloride Sales Market Share by Type (2021-2026)
Figure 58. APAC Morphine Hydrochloride Sales Market Share by Application (2021-2026)
Figure 59. China Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 63. India Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Morphine Hydrochloride Sales Market Share by Country in 2025
Figure 67. Europe Morphine Hydrochloride Revenue Market Share by Country (2021-2026)
Figure 68. Europe Morphine Hydrochloride Sales Market Share by Type (2021-2026)
Figure 69. Europe Morphine Hydrochloride Sales Market Share by Application (2021-2026)
Figure 70. Germany Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 71. France Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Morphine Hydrochloride Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Morphine Hydrochloride Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Morphine Hydrochloride Sales Market Share by Application (2021-2026)
Figure 78. Egypt Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Morphine Hydrochloride in 2026
Figure 84. Manufacturing Process Analysis of Morphine Hydrochloride
Figure 85. Industry Chain Structure of Morphine Hydrochloride
Figure 86. Channels of Distribution
Figure 87. Global Morphine Hydrochloride Sales Market Forecast by Region (2027-2032)
Figure 88. Global Morphine Hydrochloride Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Morphine Hydrochloride Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Morphine Hydrochloride Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Morphine Hydrochloride Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Morphine Hydrochloride Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Morphine Hydrochloride
Figure 2. Morphine Hydrochloride Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Morphine Hydrochloride Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Morphine Hydrochloride Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Morphine Hydrochloride Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Morphine Hydrochloride Sales Market Share by Country/Region (2025)
Figure 10. Morphine Hydrochloride Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Immediate-Release (IR)
Figure 12. Product Picture of Controlled-Release (CR)
Figure 13. Product Picture of Sustained-Release (SR)
Figure 14. Global Morphine Hydrochloride Sales Market Share by Type in 2026
Figure 15. Global Morphine Hydrochloride Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of <15 mg
Figure 17. Product Picture of 15–30 mg
Figure 18. Product Picture of 30–60 mg
Figure 19. Product Picture of 60–100 mg
Figure 20. Product Picture of >100 mg
Figure 21. Global Morphine Hydrochloride Sales Market Share by Strength in 2026
Figure 22. Global Morphine Hydrochloride Revenue Market Share by Strength (2021-2026)
Figure 23. Product Picture of Sterile Injectable Grade
Figure 24. Product Picture of Non-Sterile Oral Grade
Figure 25. Global Morphine Hydrochloride Sales Market Share by Sterility in 2026
Figure 26. Global Morphine Hydrochloride Revenue Market Share by Sterility (2021-2026)
Figure 27. Morphine Hydrochloride Consumed in Acute Pain Management
Figure 28. Global Morphine Hydrochloride Market: Acute Pain Management (2021-2026) & (K Units)
Figure 29. Morphine Hydrochloride Consumed in Chronic Pain Management
Figure 30. Global Morphine Hydrochloride Market: Chronic Pain Management (2021-2026) & (K Units)
Figure 31. Global Morphine Hydrochloride Sale Market Share by Application (2025)
Figure 32. Global Morphine Hydrochloride Revenue Market Share by Application in 2025
Figure 33. Morphine Hydrochloride Sales by Company in 2025 (K Units)
Figure 34. Global Morphine Hydrochloride Sales Market Share by Company in 2025
Figure 35. Morphine Hydrochloride Revenue by Company in 2025 ($ millions)
Figure 36. Global Morphine Hydrochloride Revenue Market Share by Company in 2025
Figure 37. Global Morphine Hydrochloride Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Morphine Hydrochloride Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Morphine Hydrochloride Sales 2021-2026 (K Units)
Figure 40. Americas Morphine Hydrochloride Revenue 2021-2026 ($ millions)
Figure 41. APAC Morphine Hydrochloride Sales 2021-2026 (K Units)
Figure 42. APAC Morphine Hydrochloride Revenue 2021-2026 ($ millions)
Figure 43. Europe Morphine Hydrochloride Sales 2021-2026 (K Units)
Figure 44. Europe Morphine Hydrochloride Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Morphine Hydrochloride Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Morphine Hydrochloride Revenue 2021-2026 ($ millions)
Figure 47. Americas Morphine Hydrochloride Sales Market Share by Country in 2025
Figure 48. Americas Morphine Hydrochloride Revenue Market Share by Country (2021-2026)
Figure 49. Americas Morphine Hydrochloride Sales Market Share by Type (2021-2026)
Figure 50. Americas Morphine Hydrochloride Sales Market Share by Application (2021-2026)
Figure 51. United States Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Morphine Hydrochloride Sales Market Share by Region in 2025
Figure 56. APAC Morphine Hydrochloride Revenue Market Share by Region (2021-2026)
Figure 57. APAC Morphine Hydrochloride Sales Market Share by Type (2021-2026)
Figure 58. APAC Morphine Hydrochloride Sales Market Share by Application (2021-2026)
Figure 59. China Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 63. India Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Morphine Hydrochloride Sales Market Share by Country in 2025
Figure 67. Europe Morphine Hydrochloride Revenue Market Share by Country (2021-2026)
Figure 68. Europe Morphine Hydrochloride Sales Market Share by Type (2021-2026)
Figure 69. Europe Morphine Hydrochloride Sales Market Share by Application (2021-2026)
Figure 70. Germany Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 71. France Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Morphine Hydrochloride Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Morphine Hydrochloride Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Morphine Hydrochloride Sales Market Share by Application (2021-2026)
Figure 78. Egypt Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Morphine Hydrochloride Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Morphine Hydrochloride in 2026
Figure 84. Manufacturing Process Analysis of Morphine Hydrochloride
Figure 85. Industry Chain Structure of Morphine Hydrochloride
Figure 86. Channels of Distribution
Figure 87. Global Morphine Hydrochloride Sales Market Forecast by Region (2027-2032)
Figure 88. Global Morphine Hydrochloride Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Morphine Hydrochloride Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Morphine Hydrochloride Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Morphine Hydrochloride Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Morphine Hydrochloride Revenue Market Share Forecast by Application (2027-2032)
More Publications
Global Acute Hepatic Porphyria Drug Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
62 pages
Global Fibromyalgia Therapeutics Drugs Market Growth 2024-2030
US$ 3,660.00
December 2024
133 pages
Global Selective Glucocorticoid Receptor Modulator Market Growth 2023-2029
US$ 3,660.00
March 2023
101 pages
Global Critical and Chronic Care Products Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
September 2024
111 pages
Global Non-Invasive Drug Delivery Device Market Growth 2024-2030
US$ 3,660.00
October 2024
108 pages